Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...
News-Medical.Net on MSN
Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...
A Korea University research team has discovered that pitavastatin, a widely used lipid-lowering drug, can directly inhibit ...
Discover how Pitavastatin, a cholesterol-lowering drug, shows promise as a treatment for triple-negative breast cancer.
Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review ...
Rescheduling could let DC legalize marijuana sales; MA anti-cannabis initiative challenge; Study: CBD combats tumors; OH’s $1 ...
An artificial saliva in the form of a mouthwash, produced with the CANECPI-5 protein extracted from sugarcane and modified in a laboratory, can aid in ...
Fannin Partners has been awarded a $300,000 Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute (NEI) to advance a first-in-class, non-VEGF–targeted therapeutic for ...
We are thrilled to welcome Arjun and Cyndi to the Compass team. They are highly accomplished leaders with decades of commercial and clinical development experience,” said Thomas Schuetz, MD, PhD, CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback